Healthcare sustainability depends on breaking down silos, bringing all stakeholders together with the patient at the centre to deliver mutual benefit. If the patient – who…
In Conversation
Latin America offers companies the opportunity to perform well and generates excellent performance examples to showcase around the world
[The dengue vaccine] is a momentous achievement for Takeda and will have a big impact on LatAm, which – along with Asia – is home to…
DIA today is a vastly different organization than it was. Our emphasis on catalyzing thought leadership and applying our global platform and channels to convene, conduct…
The issue of health is simply not a priority for the government. This is evident through the way they minimise many important aspects of the process…
In Mexico 85 percent of the medicines consumed by the population are produced in the country itself. For this reason, Mexico is considered one of the…
LatAm has an ethnically diverse population, strong doctor-patient relationships, and great clinical research centres, all of which are increasingly attracting the eye of our member companies…
Empathetic dialogue and an understanding of our shared goals, and the value that innovation brings to health systems are critical, as is facilitating enabling infrastructure, creating…
We are on a permanent learning curve with the government and pushing forward as much as we can for new molecule approvals, so patients have access…
In a complex and fast-changing environment like LatAm, there are many roadblocks to execution depending on the country, geography, or political environment. We must therefore be…
Latin America is a critical region and part of the emerging markets that can contribute to business growth, but also offer talent and diversity.
Real value comes from bringing stakeholders from the pharma, medtech, and technology industries together to create the health systems of the future
